Brain Function and Psychological Changes Related to Cell Therapy for Autoimmune Hemolytic Anemia
Recruiting
Observational Study
CAR T-cell Therapy
Autoimmune Hemolytic Anemia
Brain Function
Psychological Well-Being
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Observational
- Participants needed
- 20 (estimated)
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Cell therapy is an innovative treatment with significant efficacy in hematologic and certain autoimmune diseases. Although it offers potential benefits for autoimmune hemolytic anemia (AIHA), it may result in cognitive and other potential impairments, which can adversely affect patients' cognition and behavior.
Brain function and psychological assessment are essential for the early detection of p…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of AIHA
* Subjects will receive cell therapy such as CAR T-cell therapy
* Male or female, aged 18-65 years
* Willing and able to comply with the requirements for this study and written informed consent
Exclusion Criteria:
* History of psychiatric illness
* History …
Contacts